Changes in extracellular dopamine in the rat globus pallidus induced by typical and atypical antipsychotic drugs

Neurochemistry International

Volumn 45, Issue 7, 2004, Pages 1029-1038

  Fuchs, Holger ^a   Hauber, Wolfgang ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

Author keywords

Antipsychotic drugs; Dopamine; Globus pallidus; Microdialysis; Rat

Indexed keywords

CLOZAPINE; DOPAMINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; RACLOPRIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DOSE CALCULATION; DRUG BRAIN LEVEL; DRUG DOSE REGIMEN; DRUG EFFECT; EXTRAPYRAMIDAL SYMPTOM; GLOBUS PALLIDUS; MALE; MICRODIALYSIS; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

ANIMALS; ANTIPSYCHOTIC AGENTS; DOPAMINE; EXTRACELLULAR FLUID; GLOBUS PALLIDUS; MALE; RATS;

EID: 4444234113     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2004.05.008     Document Type: Article

References (55)

1. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-375
2. Arluison M., Dietl M., Thibault J. Ultrastructural morphology of dopaminergic nerve terminals and synapses in the striatum of the rat using tyrosine hydroxylase immunocytochemistry: a topographical study. Brain Res. Bull. 13:1984;269-285
3. Bubser M., Deutch A.Y. Differential effects of typical and atypical antipsychotic drugs on striosome and matrix compartments of the striatum. Eur. J. Neurosci. 15:2002;713-720
4. Campbell K., Kalen P., Lundberg C., Wictorin K., Rosengren E., Bjorklund A. Extracellular gamma-aminobutyric acid levels in the rat caudate-putamen: monitoring the neuronal and glial contribution by intracerebral microdialysis. Brain Res. 614:1993;241-250
5. Carlsson A., Lindqvist M. Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol. Toxicol. (Copenhagen). 20:1963;140-144
6. Chapman M.A., See R.E. Differential effects of unique profile antipsychotic drugs on extracellular amino acids in the ventral pallidum and globus pallidus of rats. J. Pharm. Exp. Ther. 277:1996;1586-1594
7. Chiodo L.A., Bunney B.S. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J. Neurosci. 3:1983;1607-1619
8. Chiodo L.A., Bannon M.J., Grace A.A., Roth R.H., Bunney B.S. Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience. 12:1984;1-16
9. Cooper A.J., Stanford I.M. Dopamine D2 receptor mediated presynaptic inhibition of striatopallidal GABA(A) IPSCs in vitro. Neuropharmacology. 41:2001;62-71
10. Costall B., Naylor R.J., Olley J.E. Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain. Neuropharmacology. 11:1972;645-663
11. Coward, D.M., 1992. General pharmacology of clozapine. Br. J. Psychiatry Suppl, pp. 5-11.
12. Cubeddu L.X., Hoffmann I.S., Talmaciu R.K. Is the release of dopamine from medial prefrontal cortex modulated by presynaptic receptors? Comparison with nigrostriatal and mesolimbic terminals. Ann. N.Y. Acad. Sci. 604:1990;452-461
13. Cumming P., Brown E., Damsma G., Fibiger H. Formation and clearance of interstitial metabolites of dopamine and serotonin in the rat striatum: an in vivo microdialysis study. J. Neurochem. 59:1992;1905-1914
14. Di Chiara G., Porceddu M.L., Fratta W., Gessa G.L. Postsynaptic receptors are not essential for dopaminergic feedback regulation. Nature. 267:1977;270-272
15. Di Chiara G. In-vivo brain dialysis of neurotransmitters. Trends Pharmacol. Sci. 11:1990;116-121
16. Drew K.L., O'Connor T.O., Kehr J., Ungerstedt U. Regional specific effects of clozapine and haloperidol on GABA and dopamine release in the basal ganglia. Eur. J. Pharmacol. 187:1990;385-397
17. Fallon J.H., Moore R.Y. Catecholamine innervation of the basal forebrain IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J. Comp. Neurol. 180:1978;545-550
18. Farde, L. and Nordstrom, A. L., 1992. PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients. Br. J. Psychiatry Suppl., 30-33.
19. Farde L., Nordstrom A.L., Wiesel F.A., Pauli S., Halldin C., Sedvall G. Positron emission tomographic analysis of central D1-dopamine and D2-dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine - relation to extrapyramidal side-effects. Arch. Gen. Psychiatry. 49:1992;538
20. Farde L., Wiesel F.A., Halldin C., Sedvall G. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch. Gen. Psychiatry. 45:1988;71-76
21. Fuchs H., Hauber W. Dopaminergic innervation of the rat globus pallidus characterized by microdialysis and immunohistochemistry. Exp. Brain Res. 154:2004;66-75
22. Gong W., Neill D.B., Justice J.B. Jr. GABAergic modulation of ventral pallidal dopamine release studied by in vivo microdialysis in the freely moving rat. Synapse. 29:1998;406-412
23. Gray A.M., Connick J.H. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism. Eur. J. Pharmacol. 362:1998;127-136
24. Gurevich E.V., Joyce J.N. Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons. Neuropsychopharmacology. 20:1999;60-80
25. Hall H., Ogren S.O., Kohler C., Magnusson O. Animal pharmacology of raclopride, a selective dopamine D2 antagonist. Psychopharmacol. Ser. 7:1989;123-130
26. Hauber W., Fuchs H. Dopamine release in the rat globus pallidus characterised by in vivo microdialysis. Behav. Brain Res. 111:2000;39-44
27. Hauber W., Lutz S. Dopamine D1 or D2 receptor blockade in the globus pallidus produces akinesia in the rat. Behav. Brain Res. 106:1999;143-150
28. Ichikawa J., Meltzer H.Y. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens. Brain Res. 858:2000;252-263
29. Kapur S., Zipursky R., Jones C., Remington G., Houle S. Relationship between dopamine D(2) occupancy, clinical response, and side-effects: a double-blind PET study of first-episode schizophrenia. Am. J. Psychiatry. 157:2000;514-520
30. Larson E.R., Ariano M.A. D3 and D2 dopamine receptors: visualization of cellular expression patterns in motor and limbic structures. Synapse. 20:1995;325-337
31. Levesque D., Diaz J., Pilon C., Martres M.P., Giros B., Souil E., Schott D., Morgat J.L., Schwartz J.C., Sokoloff P. Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. Natl. Acad. Sci. U.S.A. 89:1992;8155-8159
32. Lindvall O., Björklund A. Dopaminergic innervation of the globus pallidus by collaterals from the nigrostriatal pathway. Brain Res. 172:1979;169-173
33. Mansour A., Meador-Woodruff J.H., Bunzow J.R., Civelli O., Akil H., Watson S.J. Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization- receptor autoradiographic analysis. J. Neurosci. 10:1990;2587-2600
34. Marshall J.F., Henry B.L., Billings L.M., Hoover B.R. The role of the globus pallidus D2 subfamily of dopamine receptors in pallidal immediate early gene expression. Neuroscience. 105:2001;365-378
35. Meltzer H.Y., Chai B.L., Thompson P.A., Yamamoto B.K. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine. J. Pharmacol. Exp. Ther. 268:1994;1452-1461
36. Meltzer H.Y., Park S., Kessler R. Cognition, schizophrenia, and the atypical antipsychotic drugs. Proc. Natl. Acad. Sci. U.S.A. 96:1999;13591-13593
37. Moghaddam B., Bunney B.S. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens and striatum of the rat: an in vivo microdialysis study. J. Neurochem. 54:1990;1755
38. Mukherjee J., Christian B.T., Narayanan T.K., Shi B., Mantil J. Evaluation of dopamine D-2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride. Neuropsychopharmacology. 25:2001;476-488
39. Nguyen T.V., Kosofsky B.E., Birnbaum R., Cohen B.M., Hyman S.E. Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc. Natl. Acad. Sci. U.S.A. 89:1992;4270-4274
40. Nordstrom A.L., Farde L., Wiesel F.A., Forslund K., Pauli S., Halldin C., Uppfeldt G. Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients. Biol. Psychiatry. 33:1993;227-235
41. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego, New York.
42. Pehek E.A., Yamamoto B.K. Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen. J. Neurochem. 63:1994;2118
43. Rahman S., McBride W.J. Feedback control of mesolimbic somatodendritic dopamine release in rat brain. J. Neurochem. 74:2000;684-692
44. Robertson G.S., Fibiger H.C. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience. 46:1992;315-328
45. Ruskin D.N., Marshall J.F. Differing influences of dopamine agonists and antagonists on fos expression in identified populations of globus pallidus neurons. Neuroscience. 81:1997;79-92
46. Santiago M., Machado A., Cano J. Regulation of prefrontal cortical dopamine release by dopamine agonists and antagonists. Eur. J. Pharmacol. 329:1993;83-91
47. See R.E., Berglind W.J. Decreased pallidal GABA following reverse microdialysis with clozapine, but not haloperidol. Neuroreport. 12:2001;3655-3658
48. See R.E., Berglind W.J., Krentz L., Meshul C.K. Convergent evidence from microdialysis and presynaptic immunolabeling for the regulation of gamma-aminobutyric acid release in the globus pallidus following acute clozapine or haloperidol administration in rats. J. Neurochem. 82:2002;172-180
49. Seeman P. Antipsychotic drugs, dopamine receptors, and schizophrenia. Clin. Neurosci. Res. 1:2001;53-60
50. Seeman P., Van Tol H.H. Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15:1994;264-270
51. Sotnikova T.D., Gainetdinov R.R., Grekhova T.V., Rayevsky K.S. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study). Pharmacol. Res. 43:2001;283-290
52. Volonte M., Monferini E., Cerutti M., Fodritto F., Borsini F. BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex. J. Neurochem. 69:1997;182-190
53. Walters J.R., Roth R.H. Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors. Naunyn Schmiedeberg's Arch. Pharmacol. 296:1976;5-14
54. Weiner D.M., Levey A.I., Sunahara R.K., Niznik H.B., O'Dowd B.F., Seeman P., Brann M.R. D1 and D2 dopamine receptor mRNA in rat brain. Proc. Natl. Acad. Sci. U.S.A. 88:1991;1859-1863
55. Zetterstrom T., Sharp T., Collin A.K., Ungerstedt U. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148:1988;327-334